Immunotherapy in Advanced Hepatocellular Cancer

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
17:12

OncoAlert

Year in Review: Gastric, Esophageal, & Liver Cancer Updates

FEATURING Sharlene Gill
  • 6 views
  • April 17, 2025
13:25

14th International Gastrointestinal Cancers Conference (IGICC2024)

Management of Fibrolamellar Liver Cancer

FEATURING Sunyoung Lee
  • 11 views
  • April 9, 2025
27:57

OncoAlert

Treating GI Cancers With Limited Resources

FEATURING Noha Rashad
  • 12 views
  • April 4, 2025
19:34

The France Foundation

Guidelines for Assessment and Management for Advanced HCC

FEATURING Katie Kelley
  • 44 views
  • April 3, 2025
  • 1
17:43

The France Foundation

Data Summary and Update on Preferred Immunotherapies for Advanced HCC

FEATURING Adam Burgoyne, Katie Kelley
  • 9 views
  • April 3, 2025
13:00

The France Foundation

Multidisciplinary Case Considerations & Discussions: Advanced HCC Patient With Cirrhosis, Portal HTN, and Esophageal Varices

FEATURING Adam Burgoyne, Katie Kelley
  • 7 views
  • April 3, 2025
23:22

COR2ED The Heart of Medical Education

Advanced HCC Panel Discussion: The Use of IO in Unresectable HCC + Safety and Efficacy of IO & IO Combinations

FEATURING Rachna Shroff, Rohit Gosain, Rahul Gosain
  • 7 views
  • March 28, 2025
26:19

COR2ED The Heart of Medical Education

Advanced HCC Panel Discussion: 2L Treatment Selection and When to Switch

FEATURING Lorenza Rimassa, Arndt Vogel, Rohit Gosain, Rahul Gosain
  • 4 views
  • March 28, 2025
04:54

COR2ED The Heart of Medical Education

Use of IO in Unresectable HCC: Safety & Efficacy of IO & IO Combinations

FEATURING Rachna Shroff, Rohit Gosain, Rahul Gosain
  • 2 views
  • March 28, 2025
05:36

COR2ED The Heart of Medical Education

Integrating Multimodal Approaches With Multidisciplinary Care for Intermediate HCC

FEATURING Rohit Gosain, Rahul Gosain, Mark Yarchoan, Nina Sanford, Edward Kim
  • 12 views
  • March 10, 2025
27:13

COR2ED The Heart of Medical Education

Multidisciplinary Panel Discussion: Integrating IO Into the Management of Intermediate HCC

FEATURING Rohit Gosain, Rahul Gosain, Mark Yarchoan, Nina Sanford, Edward Kim
  • 19 views
  • March 10, 2025
19:15

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Summary: Key Trial Highlights in Hepatobiliary Cancer - ACCELERATE, RACB & CheckMate 9DW

FEATURING Richard Kim, Tiago Biachi
  • 147 views
  • March 7, 2025
05:19

COR2ED The Heart of Medical Education

Advanced HCC: 2L Treatment Selection & When to Switch

FEATURING Lorenza Rimassa, Arndt Vogel, Rohit Gosain, Rahul Gosain
  • 40 views
  • March 6, 2025
  • 2
15:58

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Summary: Intermediate HCC and the Management of Liver Disease

FEATURING Maria Reig
  • 97 views
  • March 4, 2025
  • 1
04:11

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Camrelizumab + Rivoceranib vs. Sorafenib for 1L Unresectable HCC of Viral and Non-Viral Etiology - Ph3 CARES-310 Trial

FEATURING Rachna Shroff
  • 65 views
  • February 25, 2025
20:03

14th International Gastrointestinal Cancers Conference (IGICC2024)

Optimal Sequencing of Systemic Treatment for HCC

FEATURING Sahin Lacin
  • 16 views
  • February 25, 2025
09:15

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Pt Characteristics, Treatment Patterns, and Survival Outcomes in Unresectable HCC Treated With 1L Systemic Therapy in the US

FEATURING Nguyen Tran
  • 82 views
  • February 12, 2025
07:37

The France Foundation

Multidisciplinary Tumor Board Case: Pt With Alcohol-Associated, Child-Pugh A Cirrhosis and HCC - Systemic Therapy and IO Approach

FEATURING Osman Ahmed, Anjana A. Pillai, Joseph Franses
  • 109 views
  • February 7, 2025
07:14

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Real-World Experience With Atezo + Bev in Unresectable HCC - A Multicenter Study

FEATURING Maen Abdelrahim
  • 191 views
  • February 6, 2025
18:41

14th International Gastrointestinal Cancers Conference (IGICC2024)

Overview of Key Immunotherapy Trials in Advanced HCC

FEATURING Vladimir Nikolic
  • 75 views
  • February 5, 2025
11:25

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Real-World Outcomes of Durvalumab +/- Tremelimumab in Unresectable HCC - Preliminary Results From the International DT-Real Study

FEATURING Ciro Celsa
  • 92 views
  • February 4, 2025
  • 1
29:13

The France Foundation

Treatment Approaches for Intermediate HCC: Emerging Role of Liver-Directed Therapies and Immunotherapies

FEATURING Zach Berman, Adam Burgoyne
  • 160 views
  • February 4, 2025
09:51

The France Foundation

Case Discussions: Multidisciplinary Tumor Board Considerations for a Pt With Cirrhosis and Recurrent HCC

FEATURING Adam Burgoyne, Zach Berman
  • 9 views
  • February 4, 2025
05:13

The France Foundation

Case Discussions: Multidisciplinary Tumor Board Considerations for a Non-Cirrhotic Pt With HCC, 11 cm Mass

FEATURING Adam Burgoyne, Zach Berman
  • 11 views
  • February 4, 2025
21:33

Oncology 2024 Year in Review

Year in Review 2024 - Hepatobiliary Cancers

FEATURING Richard Kim, Tiago Biachi
  • 643 views
  • December 30, 2024
  • 3

Immunotherapy in Advanced Hepatocellular Cancer

No subtopics